Czechia, April 18 -- Czechia based Merck Sharp & Dohme s.r.o. has secured contract from Nemocnice Na Homolce for Antineoplastic Agents - Pembrolizumab medicinal product. The value of the contract is worth 391890128 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....